New inhaler aims to calm asthma Flare-Ups

NCT ID NCT07241546

Recruiting now Symptom relief Sponsor: Arrowhead Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an inhaled medication called ARO-RAGE in 36 adults with mild asthma that is triggered by allergens. The goal is to see if it improves small airway function after breathing in an allergen. Participants will receive either the drug or a placebo and be monitored for lung function and side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic asthma asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

Research Site 1
RECRUITING

Vancouver, British Columbia, Canada
Research Site 2
RECRUITING

Calgary, T2N 4N1, Canada
Research Site 3
RECRUITING

Edmonton, T6G 2G3, Canada
Research Site 4
RECRUITING

Saskatoon, S7M 2W2, Canada
Research Site 5
RECRUITING

Hamilton, L8N 3Z5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.